Clinicopathological Study of Triple Negative Breast Cancers
Author(s) -
Gunadala Ishitha
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/20475.8539
Subject(s) - immunohistochemistry , breast cancer , triple negative breast cancer , oncology , basal (medicine) , medicine , pathology , estrogen receptor , progesterone receptor , estrogen , metastasis , pathological , gene expression profiling , biology , cancer , gene expression , gene , insulin , biochemistry
Triple Negative Breast Cancers (TNBC) are a subset of breast cancers which are composed of different molecular subtypes. The most common is the basal like subtype, which has an adverse prognosis and limited treatment options.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom